Regeneron Pharmaceuticals, Inc. today announced that it will hold a teleconference and webcast at 8:30 a.m. Eastern Time on Monday, November 22, to discuss results of two Phase 3 studies with VEGF Trap-Eye in Wet Age-related Macular Degeneration, VIEW …
Author: OphthalmologyWeb
Combined Latanoprost/timolol Reduces IOP, Stabilizes Anatomic Parameters For 2 Years
Long-term fixed combination latanoprost and timolol effectively reduced IOP and was well-tolerated in patients with glaucoma or ocular hypertension who changed medications, according to a study.
Marked Advancement In Cataract Surgery With OptiMedica’s Catalys Precision Laser System
Global ophthalmic device company OptiMedica Corp. has announced that results from a clinical study of its Catalys Precision Laser System were published in the peer-reviewed journal Science Translational Medicine (“Femtosecond Laser-Assisted Cataract Su…
Marked Advancement In Cataract Surgery With OptiMedica’s Catalys Precision Laser System
Global ophthalmic device company OptiMedica Corp. has announced that results from a clinical study of its Catalys Precision Laser System were published in the peer-reviewed journal Science Translational Medicine (“Femtosecond Laser-Assisted Cataract Su…
Marked Advancement In Cataract Surgery With OptiMedica’s Catalys Precision Laser System
Global ophthalmic device company OptiMedica Corp. has announced that results from a clinical study of its Catalys Precision Laser System were published in the peer-reviewed journal Science Translational Medicine (“Femtosecond Laser-Assisted Cataract Su…
Combined Latanoprost/timolol Reduces IOP, Stabilizes Anatomic Parameters For 2 Years
Long-term fixed combination latanoprost and timolol effectively reduced IOP and was well-tolerated in patients with glaucoma or ocular hypertension who changed medications, according to a study.
ZYTAZE Now Available In Pharmacies For Immediate Dispensing
OCuSOFT, Inc., an ophthalmic research, development and supply company, is pleased to announce that ZYTAZE is now available in pharmacies as a prescription-only (Rx) supplement. Pharmacies include but are not limited to: Walgreens, CVS, Wal-Mart, Rite A…
Transcription Factor Scan Identifies Genetic Cause For Inherited Blindness
Retinitis pigmentosa is an inherited eye disorder characterized by progressive loss of vision that in many instances leads to legal blindness at the end stage.
Novel Genetic Mutation That Causes The Most Common Form Of Eye Cancer Discovered
An international, multi-center study has revealed the discovery of a novel oncogene that is associated with uveal melanoma, the most common form of eye cancer. Researchers have isolated an oncogene called GNA11 and have found that it is present in more…
Laser System Developed At Stanford Shows Promise For Cataract Surgery
STANFORD, Calif. – Imagine trying to cut by hand a perfect circle roughly one-third the size of a penny. Then consider that instead of a sheet of paper, you’re working with a scalpel and a thin, elastic, transparent layer of tissue, which both offers r…
Laser System Developed At Stanford Shows Promise For Cataract Surgery
STANFORD, Calif. – Imagine trying to cut by hand a perfect circle roughly one-third the size of a penny. Then consider that instead of a sheet of paper, you’re working with a scalpel and a thin, elastic, transparent layer of tissue, which both offers r…
Transcription Factor Scan Identifies Genetic Cause For Inherited Blindness
Retinitis pigmentosa is an inherited eye disorder characterized by progressive loss of vision that in many instances leads to legal blindness at the end stage.
Novel Genetic Mutation That Causes The Most Common Form Of Eye Cancer Discovered
An international, multi-center study has revealed the discovery of a novel oncogene that is associated with uveal melanoma, the most common form of eye cancer. Researchers have isolated an oncogene called GNA11 and have found that it is present in more…
VisionCare’s Macular Degeneration Telescope Implant Named ‘Best Of What’s New’ 2010 By Popular Science
VisionCare Ophthalmic Technologies, Inc., a developer of advanced visual prosthetic devices, today announced the Implantable Miniature Telescope (by Dr. Isaac Lipshitz), designed to improve vision in patients with end-stage age-related macular degenera…
VisionCare’s Macular Degeneration Telescope Implant Named ‘Best Of What’s New’ 2010 By Popular Science
VisionCare Ophthalmic Technologies, Inc., a developer of advanced visual prosthetic devices, today announced the Implantable Miniature Telescope (by Dr. Isaac Lipshitz), designed to improve vision in patients with end-stage age-related macular degenera…
OptiMedica’s Catalys Precision Laser System Study Shows Marked Advancement In Cataract Surgery
SANTA CLARA, Calif. – Embargoed for 2 p.m. EST, November 17, 2010 – Global ophthalmic device company OptiMedica Corp. has announced that results from a clinical study of its Catalys Precision Laser System were published in the peer-reviewed journal Sci…
Digital Retinal Camera Receives 510(k) Clearance From FDA
The Canon CR-2 Digital Non-Mydriatic Retinal Camera has received U.S. Food and Drug Administration 510(k) clearance, the manufacturer announced.
Fluorescein Angiography, OCT Measurements Correlate With Visual Acuity In Eyes With DME
Fluorescein angiography, optical coherence tomography and color fundus photography showed similar associations with visual acuity in eyes treated for diabetic macular edema, a study found.
ISTA Pharmaceuticals Granted Three-Year Market Exclusivity For BROMDAY(TM)
ISTA Pharmaceuticals, Inc. , today announced the U.S. Food and Drug Administration (FDA) has granted the Company three years of marketing exclusivity for BROMDAY(TM) (bromfenac ophthalmic solution) 0.09%, as provided under the Drug Price Competition an…
Fluorescein Angiography, OCT Measurements Correlate With Visual Acuity In Eyes With DME
Fluorescein angiography, optical coherence tomography and color fundus photography showed similar associations with visual acuity in eyes treated for diabetic macular edema, a study found.